Artículo original
Análisis morfométrico del endotelio corneal tras ranibizumab intravítreo en la degeneración macular asociada a la edad
Morphometric analysis of corneal endothelium after intravitreal ranibizumab (Lucentis®) in age-related macular degeneration treatment
J. Benítez-Herreros, C. Pérez-Rico
, M.A. Teus, Y. Gómez-San Gil, M. Castro-Rebollo
Autor para correspondencia
Servicio de Oftalmología, Hospital Universitario Príncipe de Asturias, Universidad de Alcalá, Madrid, España
Leído
2512
Vecesse ha leído el artículo
771
Total PDF
1741
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 0 | 2 | 2 |
| 2025 11 | 0 | 16 | 16 |
| 2025 10 | 0 | 5 | 5 |
| 2025 9 | 0 | 4 | 4 |
| 2025 8 | 0 | 4 | 4 |
| 2025 7 | 0 | 6 | 6 |
| 2025 6 | 0 | 3 | 3 |
| 2025 5 | 0 | 3 | 3 |
| 2025 4 | 0 | 3 | 3 |
| 2025 3 | 0 | 5 | 5 |
| 2024 12 | 0 | 1 | 1 |
| 2024 11 | 0 | 2 | 2 |
| 2024 9 | 0 | 5 | 5 |
| 2024 8 | 0 | 4 | 4 |
| 2024 7 | 0 | 1 | 1 |
| 2024 6 | 0 | 5 | 5 |
| 2024 4 | 0 | 4 | 4 |
| 2024 3 | 0 | 11 | 11 |
| 2024 2 | 0 | 1 | 1 |
| 2024 1 | 0 | 2 | 2 |
| 2023 12 | 0 | 3 | 3 |
| 2023 11 | 0 | 5 | 5 |
| 2023 10 | 0 | 5 | 5 |
| 2023 9 | 0 | 2 | 2 |
| 2023 8 | 0 | 2 | 2 |
| 2023 7 | 0 | 20 | 20 |
| 2023 5 | 0 | 2 | 2 |
| 2023 4 | 0 | 1 | 1 |
| 2023 3 | 1 | 1 | 2 |
| 2023 2 | 0 | 1 | 1 |
| 2022 1 | 0 | 3 | 3 |
| 2022 11 | 0 | 1 | 1 |
| 2022 10 | 0 | 6 | 6 |
| 2022 9 | 0 | 7 | 7 |
| 2022 8 | 0 | 11 | 11 |
| 2022 6 | 0 | 4 | 4 |
| 2022 4 | 0 | 3 | 3 |
| 2022 3 | 0 | 6 | 6 |
| 2022 2 | 0 | 5 | 5 |
| 2021 1 | 0 | 2 | 2 |
| 2021 12 | 0 | 4 | 4 |
| 2021 11 | 0 | 5 | 5 |
| 2021 10 | 0 | 2 | 2 |
| 2021 9 | 0 | 1 | 1 |
| 2021 8 | 0 | 2 | 2 |
| 2021 7 | 0 | 2 | 2 |
| 2021 6 | 0 | 8 | 8 |
| 2021 4 | 0 | 7 | 7 |
| 2021 2 | 0 | 4 | 4 |
| 2020 12 | 0 | 3 | 3 |
| 2020 11 | 0 | 2 | 2 |
| 2020 10 | 0 | 2 | 2 |
| 2020 9 | 0 | 4 | 4 |
| 2020 8 | 0 | 4 | 4 |
| 2020 7 | 0 | 3 | 3 |
| 2020 6 | 0 | 1 | 1 |
| 2020 5 | 0 | 3 | 3 |
| 2020 3 | 0 | 5 | 5 |
| 2020 2 | 0 | 10 | 10 |
| 2020 1 | 0 | 3 | 3 |
| 2019 12 | 0 | 16 | 16 |
| 2019 11 | 0 | 4 | 4 |
| 2019 10 | 0 | 4 | 4 |
| 2019 9 | 0 | 5 | 5 |
| 2019 8 | 0 | 4 | 4 |
| 2019 7 | 0 | 1 | 1 |
| 2019 6 | 0 | 7 | 7 |
| 2019 5 | 0 | 25 | 25 |
| 2019 4 | 0 | 25 | 25 |
| 2019 3 | 0 | 4 | 4 |
| 2019 2 | 0 | 7 | 7 |
| 2019 1 | 0 | 1 | 1 |
| 2018 12 | 0 | 8 | 8 |
| 2018 11 | 0 | 9 | 9 |
| 2018 10 | 0 | 17 | 17 |
| 2018 2 | 1 | 0 | 1 |
| 2018 1 | 7 | 2 | 9 |
| 2017 12 | 1 | 1 | 2 |
| 2017 11 | 7 | 2 | 9 |
| 2017 10 | 7 | 4 | 11 |
| 2017 9 | 8 | 7 | 15 |
| 2017 8 | 5 | 3 | 8 |
| 2017 7 | 14 | 2 | 16 |
| 2017 6 | 10 | 3 | 13 |
| 2017 5 | 15 | 6 | 21 |
| 2017 4 | 10 | 6 | 16 |
| 2017 3 | 12 | 35 | 47 |
| 2017 2 | 7 | 6 | 13 |
| 2016 1 | 2 | 1 | 3 |
| 2016 12 | 13 | 11 | 24 |
| 2016 11 | 24 | 4 | 28 |
| 2016 10 | 28 | 6 | 34 |
| 2016 9 | 25 | 6 | 31 |
| 2016 8 | 26 | 5 | 31 |
| 2016 7 | 14 | 7 | 21 |
| 2016 6 | 23 | 10 | 33 |
| 2016 5 | 13 | 9 | 22 |
| 2016 4 | 17 | 16 | 33 |
| 2016 3 | 19 | 11 | 30 |
| 2016 2 | 17 | 10 | 27 |
| 2015 1 | 10 | 8 | 18 |
| 2015 12 | 16 | 9 | 25 |
| 2015 11 | 18 | 6 | 24 |
| 2015 10 | 23 | 12 | 35 |
| 2015 9 | 10 | 6 | 16 |
| 2015 8 | 9 | 3 | 12 |
| 2015 7 | 13 | 7 | 20 |
| 2015 6 | 8 | 6 | 14 |
| 2015 5 | 11 | 1 | 12 |
| 2015 4 | 10 | 14 | 24 |
| 2015 3 | 9 | 8 | 17 |
| 2015 2 | 7 | 10 | 17 |
| 2015 1 | 26 | 10 | 36 |
| 2014 12 | 52 | 11 | 63 |
| 2014 11 | 19 | 8 | 27 |
| 2014 10 | 49 | 7 | 56 |
| 2014 9 | 32 | 3 | 35 |
| 2014 8 | 27 | 6 | 33 |
| 2014 7 | 44 | 5 | 49 |
| 2014 6 | 32 | 13 | 45 |
| 2014 5 | 25 | 14 | 39 |
| 2014 4 | 13 | 7 | 20 |
| 2014 3 | 23 | 7 | 30 |
| 2014 2 | 19 | 4 | 23 |
| 2014 1 | 13 | 4 | 17 |
| 2013 12 | 18 | 2 | 20 |
| 2013 11 | 12 | 5 | 17 |
| 2013 10 | 21 | 2 | 23 |
| 2013 9 | 15 | 5 | 20 |
| 2013 8 | 11 | 1 | 12 |
| 2013 7 | 7 | 4 | 11 |
| 2013 6 | 0 | 1 | 1 |
| 2010 9 | 813 | 0 | 813 |
Mostrar todo
